A high level of fatigue among long-term survivors of non-hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

Haematologica

Volumn 98, Issue 3, 2013, Pages 479-486

  Oerlemans, Simone ^a,b   Mols, Floortje ^a,b   Issa, Djamila E ^c   Pruijt, J H F M ^d   Peters, Wim G ^e   Lybeert, Marnix ^e   Zijlstra, Wobbe ^b   Coebergh, Jan Willem W ^a,f   van de Poll Franse, Lonneke V ^a,b  

^a Eindhoven   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JEROEN BOSCH HOSPITAL   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DETERIORATION; DIARRHEA; DISEASE ASSOCIATION; DYSPNEA; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; FINANCIAL DEFICIT; FOLLICULAR LYMPHOMA; HEALTH SURVEY; HUMAN; LARGE CELL LYMPHOMA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHODGKIN LYMPHOMA; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; SURVIVOR; COMPLICATION; MIDDLE AGED; REGISTER; RISK; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FATIGUE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; POPULATION SURVEILLANCE; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SURVIVORS;

EID: 84874531259     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.064907     Document Type: Article

References (48)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011, accessed on May 10, 2011.
2. US National Coalition for Cancer Survivorship. http://www.canceradvoca-cy.org/, accessed on December 28, 2009.
3. Kankerbestrijding SvK. Kanker in Nederland tot 2020, Trends en prognoses. http://www.kankerbestrijding.nl. 2011.
4. van de Schans SA, Issa DE, Visser O, Nooijen P, Huijgens PC, Karim-Kos HE, et al. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol. 2012;23(1):171-82.
5. Geffen DB, Blaustein A, Amir MC, Cohen Y. Post-traumatic stress disorder and quality of life in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma in Israel. Leuk Lymphoma. 2003;44(11):1925-9.
6. Ng AK, LaCasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol. 2011;29(14):1885-92.
7. Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(3):3806.
8. Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol. 1986;4(5):805-14.
9. Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH. Fatigue in longterm Hodgkin's disease survivors: a followup study. J Clin Oncol. 2005;23(27): 6587-95.
10. Hjermstad MJ, Oldervoll L, Fossa SD, Holte H, Jacobsen AB, Loge JH. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer. 2006;42(3):327-33.
11. Knobel H, Loge J, Brit Lund M, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol. 2001;19(13):3226-33.
12. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol. 1999;10(1):71-7.
13. Bellizzi KM, Rowland JH, Arora NK, Hamilton AS, Miller MF, Aziz NM. Physical activity and quality of life in adult survivors of non-Hodgkin's lymphoma. J Clin Oncol. 2009;27(6):960-6.
14. Doorduijn J, Buijt I, Holt B, Steijaert M, Uyl-de Groot C, Sonneveld P. Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy. Eur J Haematol. 2005;75(2):116-23.
15. Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S, Cavallin-Stahl E. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol. 2001;18(1):85-94.
16. Merli F, Bertini M, Luminari S, Mozzana R, Berte R, Trottini M, et al. Quality of life assessment in elderly patients with aggressive non-Hodgkin's lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi. Haematologica. 2004;89(8):973-8.
17. Mols F, Aaronson NK, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Lybeert ML, van de Poll-Franse LV. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer. 2007;109(8):1659-67.
18. Pettengell R, Donatti C, Hoskin P, Poynton C, Kettle PJ, Hancock B, et al. The impact of follicular lymphoma on health-related quality of life. Ann Oncol. 2008;19(3):5706.
19. Smith SK, Crespi CM, Petersen L, Zimmerman S, Ganz PA. The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors. Psychooncology. 2010;19(12):1259-67.
20. Smith SK, Zimmerman S, Williams CS, Zebrack BJ. Health status and quality of life among non-Hodgkin lymphoma Cancer. 2009;115(14):3312-23.
21. Vallance JK, Courneya KS, Jones LW, Reiman T. Differences in quality of life between non-Hodgkin's lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology. 2005;14(11):979-91.
22. Fritz A, Percy C, Jack A, Shanmugaratnam, K, Sobin L, Parkin, et al. International Classification of Diseases for Oncology (3rd ed). Geneva, World Health Organisation. 2000.
23. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-76.
24. Michielsen HJ, De Vries J, Drent M, Peros-Golubicic T. Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(2):133-8.
25. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res. 2003;54(4):345-52.
26. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156-63.
27. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31(11): 1860-1.
28. van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14): 2188-94.
29. van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 2010;47(5):667-75.
30. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidencebased guidelines for determination of sam-ple size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011; 29(1):89-96.
31. Cocks K, King MT, Velikova G, de Castro G Jr, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer. 2012; 48(11):1713-21.
32. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-92.
33. Blaes AH, Ma L, Zhang Y, Peterson BA. Quality of life appears similar between survivors of indolent and aggressive nonHodgkin lymphoma. Leuk Lymphoma. 2011;52(11):2105-10.
34. Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J. ancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int. 2012;109(9):161-71; quiz 172.
35. Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R. Fatigue in cancer survivors--prevalence and correlates. Onkologie. 2009;32(6):312-7.
36. Singer S, Kuhnt S, Zwerenz R, Eckert K, Hofmeister D, Dietz A, et al. Age and sex standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer. 2011;105(3):445-51.
37. Berger AM, Gerber LH, Mayer DK. Cancer fatigue: implications for breast cancer survivors. Cancer. 2011;118(8 Suppl): 2261-9.
38. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 2007;12 (Suppl 1):11-21.
39. Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010;8(8):958-66.
40. Seyidova-Khoshknabi D, Davis MP, Walsh D. Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care. 2011; 28(2):119-29.
41. Ray M, Rogers LQ, Trammell RA, Toth LA. Fatigue and sleep during cancer and chemotherapy: translational rodent models. Comp Med. 2008;58(3):234-45.
42. Hwang SS, Chang VT, Rue M, Kasimis B. Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003;26(1):604-14.
43. Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer 2001;92(6 Suppl):1664-8.
44. Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007;12 (Suppl 1):52-67.
45. Portenoy RK. Cancer-related fatigue: An immense problem. Oncologist. 2000;5(5): 350-2.
46. Tsai LY, Li IF, Lai YH, Liu CP, Chang TY, Tu CT. Fatigue and its associated factors in hospice cancer patients in Taiwan. Cancer Nurs. 2007;30(1):24-30.
47. Campos MP, Hassan BJ, Riechelmann R, Del Giglio A. Cancer-related fatigue: a practical review. Ann Oncol. 2011;22(6):1273-9.
48. Goedendorp MM, Peters ME, Gielissen MF, Witjes JA, Leer JW, Verhagen CA, Bleijenberg G. Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist. 2010;15 (10):1122-32.